NCT01143168 - Stem Cell Therapy for Type 1 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

December 31, 2011

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL

autologous bone marrow mononuclear cells and umbilical cord mesenchymal stem cells

First Transplantation: after finishing all required examines according to protocol on Day 0, ABM-MNCs + UCMSCs are transplanted through pancreas artery percutaneously; Second Transplantation: after finishing all required examines on Day 7±1, BM-MNCs UCMSCs are transplanted intravenously; Third Transplantation: after finishing all required examines on Day 14±2, BM-MNCs + UCMSCs are transplanted intravenously.

Trial Locations (1)

100085

Armed Police General Hospital, P. R. China, Beijing